Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial [0.03%]
坎格列净对2型糖尿病和慢性肾病患者贫血的影响：CREDENCE试验的事后分析
Megumi Oshima,Brendon L Neuen,Meg J Jardine et al.
Megumi Oshima et al.
Background: Sodium-glucose co-transporter 2 inhibitors might enhance erythropoiesis and increase red blood cell mass. We assessed the long-term effects of canagliflozin on anaemia-related outcomes. ...
Randomized Controlled Trial
The lancet. Diabetes & endocrinology. 2020 Nov;8(11):903-914. DOI:10.1016/S2213-8587(20)30300-4 2020
Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study [0.03%]
美国明尼苏达州Olmsted县肾上腺肿瘤的流行病学：一项基于人群的队列研究
Andreas Ebbehoj,Dingfeng Li,Ravinder J Kaur et al.
Andreas Ebbehoj et al.
Background: Adrenal tumours are commonly encountered in clinical practice, but epidemiological data mainly originate from referral centres. We aimed to determine incidence, prevalence, and rates of malignancy and hormone ...
Urine metabolomic phenotyping for detection of adrenocortical carcinoma: still a long way to go - Authors' reply [0.03%]
尿液代谢表型分析在肾上腺皮质癌检测中的应用——任重而道远——作者回复
Irina Bancos,Angela E Taylor,Vasileios Chortis et al.
Irina Bancos et al.
Urine metabolomic phenotyping for detection of adrenocortical carcinoma: still a long way to go [0.03%]
尿代谢物表型检测肾上腺皮质癌：还有很长的路要走
Panagiota Anyfanti,Barbara Nikolaidou,Eugenia Gkaliagkousi
Panagiota Anyfanti
Bone mineral density as a surrogate biomarker for fracture risk reduction - Authors' reply [0.03%]
骨密度作为骨折风险降低的替代生物标志物-作者回复
Dennis M Black,Mary L Bouxsein,Douglas C Bauer et al.
Dennis M Black et al.
Bone mineral density as a surrogate biomarker for fracture risk reduction [0.03%]
骨矿物质密度作为骨折风险降低的替代生物标志物
Josivan G Lima,Lucia H C Nóbrega,Marcel C F Santos et al.
Josivan G Lima et al.
Bone mineral density as a surrogate biomarker for fracture risk reduction [0.03%]
骨矿物密度作为骨折风险降低的替代生物标志物
Viral N Shah
Viral N Shah
Quan-Yang Duh
Quan-Yang Duh
The Lancet Diabetes Endocrinology
The Lancet Diabetes Endocrinology
The Lancet Diabetes Endocrinology
The Lancet Diabetes Endocrinology